Paul Barr (@paulbarrmd) 's Twitter Profile
Paul Barr

@paulbarrmd

ID: 1440506876072894464

calendar_today22-09-2021 02:43:21

28 Tweet

35 Followers

32 Following

Rochester New York FC (@rnyfcofficial) 's Twitter Profile Photo

The legacy and spirit of the Rochester Rhinos is ingrained in us and it will stay this way forever. However, after a break from the game and a fresh start with our new co-owner, we have the opportunity to re-launch and reposition ourselves as a global brand in football #RNYFC

Wilmot Cancer Institute (@wilmotcancer) 's Twitter Profile Photo

New The Lancet study led by Wilmot researcher Dr. Supriya Mohile (@rochgerionc) proves geriatric assessment benefits cancer patients age 70+. The results are potentially practice changing. #gerionc #URochesterResearch bit.ly/3nZ9xIL

Mahmoud Aljurf (@aljurf100) 's Twitter Profile Photo

Deeply saddened to hear about the loss of my highly valued life time friend and colleague,Dr Steven Coutre. Being fellows together at Stanford almost 30 years back was a great opportunity to learn from his exceptional manners, fine intellect and highest quality care Stanford Medicine

Deeply  saddened to hear about the loss of my highly valued life time friend and colleague,Dr Steven Coutre. Being fellows together at Stanford almost 30 years back was a great opportunity to learn from his exceptional manners, fine intellect and highest quality care <a href="/StanfordMed/">Stanford Medicine</a>
LYMPHOMA & MYELOMA CONNECT (@lym_mm_connect) 's Twitter Profile Photo

Meet our team of international experts in the field of #lymphoma. They share updates from congresses, discuss scientific data and create educational resources for HCPs around the world. Find out more: ow.ly/C2Vh50GRHhs #lymsm #MedEd

Meet our team of international experts in the field of #lymphoma. They share updates from congresses, discuss scientific data and create educational resources for HCPs around the world. Find out more: ow.ly/C2Vh50GRHhs 
#lymsm #MedEd
ECOG-ACRIN Cancer Research Group (@eaonc) 's Twitter Profile Photo

Trial Activation: EA5221/ACHIEVE, led by Megan Baumgart, MD of UR Medicine & @DrSteveMartin of Albert Einstein College of Medicine - Official, is a randomized phase III study of chemo-immunotherapy vs #immunotherapy alone for the vulnerable older adult with advanced non-small cell #lungcancer. bit.ly/ea5221-achieve

Trial Activation: EA5221/ACHIEVE, led by Megan Baumgart, MD of <a href="/UR_Med/">UR Medicine</a> &amp; @DrSteveMartin of <a href="/EinsteinMed/">Albert Einstein College of Medicine - Official</a>, is a randomized phase III study of chemo-immunotherapy vs #immunotherapy alone for the vulnerable older adult with advanced non-small cell #lungcancer. bit.ly/ea5221-achieve